Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Calreticulin is released from activated neutrophils and binds to C1q and mannan-binding protein.

Eggleton P, Lieu TS, Zappi EG, Sastry K, Coburn J, Zaner KS, Sontheimer RD, Capra JD, Ghebrehiwet B, Tauber AI.

Clin Immunol Immunopathol. 1994 Sep;72(3):405-9.

PMID:
8062452
2.

Evidence that C1q binds specifically to CH2-like immunoglobulin gamma motifs present in the autoantigen calreticulin and interferes with complement activation.

Kovacs H, Campbell ID, Strong P, Johnson S, Ward FJ, Reid KB, Eggleton P.

Biochemistry. 1998 Dec 22;37(51):17865-74.

PMID:
9922153
3.

The C1q-binding cell membrane proteins cC1q-R and gC1q-R are released from activated cells: subcellular distribution and immunochemical characterization.

Peterson KL, Zhang W, Lu PD, Keilbaugh SA, Peerschke EI, Ghebrehiwet B.

Clin Immunol Immunopathol. 1997 Jul;84(1):17-26.

PMID:
9191880
4.

Collectins and collectin receptors in innate immunity.

Holmskov UL.

APMIS Suppl. 2000;100:1-59. Review.

PMID:
11021254
5.

Localisation of the C1q binding site within C1q receptor/calreticulin.

Stuart GR, Lynch NJ, Lu J, Geick A, Moffatt BE, Sim RB, Schwaeble WJ.

FEBS Lett. 1996 Nov 18;397(2-3):245-9.

6.

Characterization of the human neutrophil C1q receptor and functional effects of free ligand on activated neutrophils.

Eggleton P, Ghebrehiwet B, Coburn JP, Sastry KN, Zaner KS, Tauber AI.

Blood. 1994 Sep 1;84(5):1640-9.

7.

The C1q and collectin binding site within C1q receptor (cell surface calreticulin).

Stuart GR, Lynch NJ, Day AJ, Schwaeble WJ, Sim RB.

Immunopharmacology. 1997 Dec;38(1-2):73-80.

PMID:
9476117
8.

Complement component C1 and the collectins--first-line defense molecules in innate and acquired immunity.

Reid KB, Colomb M, Petry F, Loos M.

Trends Immunol. 2002 Mar;23(3):115-7. No abstract available.

PMID:
11864828
9.

Release of calreticulin from neutrophils may alter C1q-mediated immune functions.

Kishore U, Sontheimer RD, Sastry KN, Zaner KS, Zappi EG, Hughes GR, Khamashta MA, Strong P, Reid KB, Eggleton P.

Biochem J. 1997 Mar 1;322 ( Pt 2):543-50.

10.

Interaction of C1q with the receptor calreticulin requires a conformational change in C1q.

Steinø A, Jørgensen CS, Laursen I, Houen G.

Scand J Immunol. 2004 May;59(5):485-95.

11.

C1q inhibits autoantibody binding to calreticulin.

Racila DM, Sontheimer RD.

Lupus. 1999;8(4):300-4.

PMID:
10413209
12.
13.
14.

Interaction of C1q and the collectins with the potential receptors calreticulin (cC1qR/collectin receptor) and megalin.

Sim RB, Moestrup SK, Stuart GR, Lynch NJ, Lu J, Schwaeble WJ, Malhotra R.

Immunobiology. 1998 Aug;199(2):208-24. Review.

PMID:
9777407
15.

Anti-C1q receptor/calreticulin autoantibodies in patients with systemic lupus erythematosus (SLE).

van den Berg RH, Siegert CE, Faber-Krol MC, Huizinga TW, van Es LA, Daha MR.

Clin Exp Immunol. 1998 Feb;111(2):359-64.

16.
17.

Isolation, cDNA cloning, and overexpression of a 33-kD cell surface glycoprotein that binds to the globular "heads" of C1q.

Ghebrehiwet B, Lim BL, Peerschke EI, Willis AC, Reid KB.

J Exp Med. 1994 Jun 1;179(6):1809-21.

18.

A calreticulin-like molecule from the human hookworm Necator americanus interacts with C1q and the cytoplasmic signalling domains of some integrins.

Kasper G, Brown A, Eberl M, Vallar L, Kieffer N, Berry C, Girdwood K, Eggleton P, Quinnell R, Pritchard DI.

Parasite Immunol. 2001 Mar;23(3):141-52.

19.

Role of surfactant proteins A, D, and C1q in the clearance of apoptotic cells in vivo and in vitro: calreticulin and CD91 as a common collectin receptor complex.

Vandivier RW, Ogden CA, Fadok VA, Hoffmann PR, Brown KK, Botto M, Walport MJ, Fisher JH, Henson PM, Greene KE.

J Immunol. 2002 Oct 1;169(7):3978-86.

Supplemental Content

Support Center